|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Neurologia e Neurocirurgia, Universidade Federal de Sao Paulo - UNIFESP, Sao Paulo, SP, Brazil; Neurology and Physiology, University of California at Los Angeles - UCLA, Los Angeles, California, USA
2 Neurology and Physiology, University of California at Los Angeles - UCLA, Los Angeles, California, USA
* To whom correspondence should be addressed. E-mail: mody{at}ucla.edu.
In the brain, spreading depression (SD) is characterized by a large extracellular DC shift, a massive failure of ion homeostasis and a transient cessation of neuronal function. Clinically, SD is believed to be involved in various neurological disorders including migraine and cerebrovascular diseases. The propagation of cortical SD requires the release of glutamate, and NMDA receptors play a crucial role in this process. Here, we have isolated the NMDA-receptor-mediated component of extracellularly recorded field EPSPs (fEPSPs) in layers 2-3 of the entorhinal cortex of murine brain slices. In the absence of GABAA and AMPA receptor mediated synaptic transmission, stimulation of layer 6 afferents every 15 - 90 s elicited spontaneous SD on average within 18.5 min after the start of the stimulation. In the presence of ifenprodil, an NR2B receptor subunit-selective NMDA receptor antagonist, the occurrence of SD was nearly abolished. Our results are consistent with an important role of NR2B subunits in triggering SD in the entorhinal cortex.
This article has been cited by other articles:
![]() |
M. Peeters, M. J. Gunthorpe, P. J. L. M. Strijbos, P. Goldsmith, N. Upton, and M. F. James Effects of Pan- and Subtype-Selective N-Methyl-D-aspartate Receptor Antagonists on Cortical Spreading Depression in the Rat: Therapeutic Potential for Migraine J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 564 - 572. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |